Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026)

Lensar's (LNSR) quarterly Net Income towards Common Stockholders came in at $18.9 million in Q1 2026, up 169.17% year-on-year from $7.0 million in Q1 2025, and up 1397.26% on a QoQ basis from -$1.5 million in Q4 2025.

Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of Net Income towards Common Stockholders data on file, last reported at $18.9 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 169.17% year-over-year to $18.9 million in Q1 2026; TTM through Mar 2026 was $12.0 million, a 121.17% increase from a year earlier, with the FY2025 full-year figure at -$34.3 million, down 9.16% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $18.9 million, up from -$1.5 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for LNSR reached as high as $18.9 million in Q1 2026 and fell as low as -$27.3 million in Q1 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$4.8 million across 5 years, with a median of -$3.9 million in 2023.
  • Across the five-year window, Net Income towards Common Stockholders plunged 1167.73% in 2025 and soared 169.17% in 2026, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$2.5 million in 2022, then slumped by 57.67% to -$3.9 million in 2023, then slumped by 376.36% to -$18.7 million in 2024, then jumped by 92.2% to -$1.5 million in 2025, then soared by 1397.26% to $18.9 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $18.9 million in Q1 2026, -$1.5 million in Q4 2025, and -$3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Lensar 65.43 Mn 54.33 Mn 6.38 Mn 18.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.91 Mn
Dec 31, 2025 -1.46 Mn
Sep 30, 2025 -3.71 Mn
Jun 30, 2025 -1.76 Mn
Mar 31, 2025 -27.35 Mn
Dec 31, 2024 -18.70 Mn
Sep 30, 2024 -1.50 Mn
Jun 30, 2024 -9.04 Mn
Mar 31, 2024 -2.16 Mn
Dec 31, 2023 -3.93 Mn
Sep 30, 2023 1.43 Mn
Jun 30, 2023 -8.75 Mn
Mar 31, 2023 -4.27 Mn
Dec 31, 2022 -2.49 Mn
Sep 30, 2022 -3.99 Mn
Jun 30, 2022 -6.76 Mn
Mar 31, 2022 -6.67 Mn
Dec 31, 2021 -3.90 Mn
Sep 30, 2021 -6.16 Mn
Jun 30, 2021 -4.36 Mn